Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-335,441
Closed -$4.57M 302
2025
Q2
$4.57M Buy
+335,441
New +$3.17M 0.69% 56
2024
Q2
Sell
-411,610
Closed -$4.23M 301
2024
Q1
$4.23M Sell
411,610
-121,602
-23% -$899K 0.66% 48
2023
Q4
$4.42M Buy
533,212
+56,684
+12% +$407K 0.78% 17
2023
Q3
$2.98M Hold
476,528
0.57% 32
2023
Q2
$2.07M Buy
+476,528
New +$1.06M 0.38% 102

Other funds holding LFMD

EAM Investors's LFMD Position: Q3 2025 in Review

EAM Investors sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 335,441 shares — an estimated $4.57M sold.

EAM Investors first reported a position in LFMD in Q2 2023 and held it in 5 quarters. The position peaked at $4.57M in Q2 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

  • EAM Investors reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
  • EAM Investors sold 335,441 LifeMD shares in Q3 2025, an estimated $4.57M.
  • EAM Investors first reported a position in LifeMD in Q2 2023 and held it in 5 quarters.
  • EAM Investors's LifeMD position peaked at $4.57M in Q2 2025.
  • 114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on EAM Investors's 13F filing for Q3 2025, filed 14 Nov 2025.